Pharmacoeconomic analysis of the choice of antimicrobial drugs for the treatment of community-acquired pneumonia by physicians and final year medical students

The authors of the article conduct a pharmacoeconomic analysis of antimicrobial agents (AMA) prescriptions based on a survey of graduates of the medical faculty of a medical university and outpatient healthcare practitioners in Moscow. In addition to the pharmacoepidemiological part, the article also contains a pharmacoeconomic aspect to obtain a more complete picture, reflecting the choice of drugs not only in primary healthcare, but also among graduates of the medical faculty, who can potentially become its members without preliminary training in medical residency.

The purpose of this study is to conduct a comparative pharmacoeconomic analysis of the AMA choice in the treatment of community-acquired pneumonia based on the data of a survey of general practitioners, district physicians and graduates of the medical faculty.

Methodology. The 206 physicians took part in the anonymous voluntary survey.

Results. 177 (85.9 %) of surveyed doctors were women and 62 (14.1 %) were men who made up Group 1. The average age of the surveyed doctors was 47.8±13.3 years, the average medical experience was 21.4±13.4 years. Group 2 consisted of 240 students, of which 178 were women (74.17 %) and 62 were men (25.83 %). The average age of the respondents in the group 2 was 24.8±3.3 years. When calculating the average cost of a treatment course of community-acquired pneumonia, depending on the structure of prescriptions, the value in Group 1 amounted to 420.82 rubles and 367.44 rubles in Group 2, while the share of costs for aminopenicillin drugs directly recommended for prescription to treat community-acquired pneumonia amounted to 8.35 and 4.97 %, respectively. Despite the current recommendations, respondents prefer to choose second-line AMAs, which are more expensive drugs. Respondents in both groups underestimate the first-line drugs that meet the current recommendations, namely aminopenicillins. Despite their low cost and ease of use in an outpatient setting, the frequency of their prescription remains low. The authors believe that more attention should be paid to the problem of rational use of antimicrobial agents. This problem can be solved through educational interventions at all levels of education, which can change the picture of drugs prescriptions in future, will allow practitioners and graduates of medical faculties to refer more often to clinical guidelines and patient treatment protocols. Comprehensive measures in this direction can not only positively affect the quality of medical care, but also reduce antibiotic resistance in the outpatient setting.

1. De Vries TPGM, Henning RG, Hogerzail GV, Friesl DA. Guide to Good Prescribing. Geneva, 1997, 114 p. (In Russ). Электронный ресурс: http://apps.who.int/medicinedocs/documents/s21726ru/s21726ru.pdf, дата доступа 30.11.2020.

2. Rachina SA, Kozlov RS, Belkova YuA. Pharmacoepidemiology: from Theory to Practice. Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology. 2014;7(1):33-39. (In Russ).

3. Decree of the President of the Russian Federation of June 6, 2019 N 254 «On the Strategy for the Development of Healthcare in the Russian Federation for the Period until 2025». (In Russ). Электронный ресурс: http://base.garant.ru/72264534/#ixzz6f5hnQDrK, дата доступа 28.11.2020.

4. Metodicheskie rekomendacii po provedeniju sravnitel’noj kliniko-jekonomicheskoj ocenki lekarstvennogo preparata (novaja redakcija) / Omel’janovskij VV, Avksent’eva MV, Sura MV i dr. — M.: FGUP «Izdatel’stvo «Nauka», 2019. — 48 p. (In Russ).

5. Gomon YM, Kolbin AS, Mazurenko SO, Ivanov IG. Principles of Clinical and Economic Analysis of Antimicrobial Drugs. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2019;(2):35-44. (In Russ). DOI: 10.24411/2588-0519-2019-10071.

6. Mishakin TS. Improving the Management of Primary Care Level in a System of Regional Health Services. Modern Problems of Science and Education. — 2012. — № 2. (In Russ). Электронный ресурс: http://science-education.ru/ru/article/view?id=5972, дата доступа 30.11.2020.

7. Deriushkin VG, Gatsura SV. Assessing the Competency of the Rational Choice of Medicines by Final Year Medical Students. Modern Problems of Science and Education. — 2020. — № 1. — P. 70. (In Russ). DOI: 10.17513/spno.29528.

8. Deriushkin VG, Ternavskij AP, Uljanova EA, Gatsura SV. The Choice of Antibiotic for Community-Acquired Pneumonia — the Results of a Survey of Doctors and an Analysis of Real Outpatient Practice. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2019;(4):50—54. (In Russ). DOI: 10.1016/2588-0519-2019-4-50-54.

9. Deriushkin VG, Gatsura OA, Gatsura SV. Administration of Antimicrobial Drugs for the Outpatient Treatment of Community-Acquired Pneumonia: Results of Survey. Bulletin «Biomedicine and Sociology». 2020;5(2):79—87. (In Russ). DOI: 10.26787/nydha-2618-8783-2020-5-2-79-87.

10. Deriushkin VG. Priverzhennost’ klinicheskim rekomendaciyam pri lechenii vnebol’nichnoj pnevmonii v ambulatornyh usloviyah — rezul’taty anketirovaniya studentov i vrachej. V kn.: Racional’naya farmakoterapiya «Zolotaya osen»: sbornik materialov XV mezhdunarodnogo nauchnogo kongressa. Pod red. AK Hadzhidisa. SPb.: 2020. — P. 53—56. (In Russ).

11. Lazareva NB. Ambulatornaya terapiya infekcij nizhnih dyhatel’nyh putej. Medicinskij sovet. 2012;(3):10—15. (In Russ). Электронный доступ: https://cyberleninka.ru/article/n/ambulatornaya-terapiya-infektsiy-nizhnih-dyhatelnyh-putey, дата доступа 28.11.2020.

12. Zyryanov SK, Butranova OI. Modern Approaches to the Rational Choice of Antibiotic for Treatment of Community-Acquired Pneumonia in Various Categories of Patients. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2019;(1):97-113. (In Russ). DOI: 10.24411/2588-0519-2019-10067.

13. Zajcev AA. Antibakterial’naya terapiya infekcij dyhatel’nyh putej: prakticheskie rekomendacii. Medicinskij sovet. 2016;(5):60-63. (In Russ). DOI: 10.21518/2079-701X-2016-05-60-63.

14. Aleksandrov MV, Ushakova SE, Budnikova NV et al. Pharmacoeconomic Aspects of the Treatment of Community-Acquired Pneumonia in Outpatients. Lechebnoe delo. 2016;(3):29-36. (In Russ).

15. The State Register of Maximum Ex-Works Prices. (In Russ). Электронный ресурс: http://grls.rosminzdrav.ru/pricelims.aspx, дата доступа 29.11.2020.

16. Order of the Ministry of Health of Russia from 29.12.2012 N 1658n «About the Approval of the Standard of Specialized Medical Care for Moderate Pneumonia» (Registered with the Ministry of Justice of Russia 13.02.2013 N 27046). (In Russ.) Электронный ресурс: https://www.rosminzdrav.ru/documents/9006-prikaz-ministerstva-zdravoohraneniyarossiyskoy-federatsii-ot-29-dekabrya-2012-g-1658n-ob-utverzhdeniistandarta-spetsializirovannoy-meditsinskoy-pomoschi-pri-pnevmoniisredney-stepeni-tyazhesti, дата доступа 20.10.2020.

17. Vnebolnichnaja pnevmonia. Algoritmy vedenija pacientov. Departament zdravoohranenija g. Moskvy. Moskva. 2018:58-63. (In Russ).

18. Deriushkin VG, Ternavskij AP, Gatsura SV. Pharmacoeconomic Analysis of First-Choice Antimicrobial Drugs Prescribed for Outpatient Treatment of non-Severe CommunityAcquired Pneumonia. Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology. 2020;13(4):329-336. (In Russ). DOI: 10.17749/2070-4909/farmakoekonomika.2020.048.

19. Tariff Agreement for the Payment of Medical Care Provided under the Territorial Program of Compulsory Medical Insurance of the City of Moscow for 2019. (In Russ). Электроннный ресурс: https://www.mgfoms.ru/system/fi les/prilozhenie_no_6_k_tarifnomu_soglasheniyu_na_2019_god.pdf, дата доступа 29.09.2020.

20. Gatsura SV, Deriushkin VG, Gatsura OA. Antimicrobial Agent Choice for Outpatient Treatment of non-Severe Community-Acquired Pneumonia — Moscow Prescribers Choice and Real Practice. In Book: European Drug Utilisation Research Group Conference EuroDURG 2020. Medicines: Benefi ts and Burdens. Abstract Book. 2020. P. 77.

21. Gatsura S, Deriushkin V, Gatsura O, Ulyanova E. Will Mild Atypical Pneumonia Remain Underdiagnosed and Undertreated in Primary Care Setting? European Journal of Public Health. 2020;30(5):835-836. DOI: 10.1093/eurpub/ckaa166.823.